De Beers Group Plc:企業の戦略・SWOT・財務情報

◆英語タイトル:De Beers Group Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6685
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ボツワナ
◆産業分野:金属・鉱業
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥23,450見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥46,900見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥70,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

De Beers Group Plc – Strategy, SWOT and Corporate Finance Report
Summary

De Beers Group Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

De Beers Group Plc (De Beers), a subsidiary of Anglo American Plc, is a diamond mining and marketing company. It carries out the exploration, mining and marketing of rough diamonds. The company produces and markets rough diamonds from its mining operations located in Botswana, Namibia, South Africa and Canada. The company operates through five projects, namely, Cut-8, Letlhakane Mine Tailings, Gahcho Kue mine, Venetia mine and motor vessel (mv) SS Nujoma. It also offers Forevermark branded diamonds and owns a patented technology to inscribe a unique identification number on the diamond. The company has operations in the UK, Namibia, South Africa, India, China, Singapore and Canada. De Beers is headquartered in Gaborone, Botswana.

Scope

- Detailed information on De Beers Group Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting De Beers Group Plc in the form of a SWOT analysis
- An in-depth view of the business model of De Beers Group Plc including a breakdown and examination of key business segments
- Intelligence on De Beers Group Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about De Beers Group Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of De Beers Group Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess De Beers Group Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on De Beers Group Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
De Beers Group Plc: Company Overview 9
De Beers Group Plc: Overview and Key Facts 9
De Beers Group Plc: Overview 9
De Beers Group Plc: Key Facts 9
De Beers Group Plc: Key Employees 10
De Beers Group Plc: Key Employee Biographies 12
De Beers Group Plc: Major Products and Services 13
De Beers Group Plc: Company History 14
De Beers Group Plc: Locations and Subsidiaries 21
De Beers Group Plc: Key Competitors 23
De Beers Group Plc: Company Analysis 24
De Beers Group Plc: Business Description 24
De Beers Group Plc: SWOT Analysis 26
De Beers Group Plc: SWOT Overview 26
De Beers Group Plc: Strengths 26
De Beers Group Plc: Weaknesses 27
De Beers Group Plc: Opportunities 27
De Beers Group Plc: Threats 28
De Beers Group Plc: Corporate Financial Deals Activity 29
De Beers Group Plc: Financial Deals Overview 29
De Beers Group Plc: Targets and Partners 31
De Beers Group Plc: Top Deals 2014 – 2018YTD* 32
De Beers Group Plc: Advisors 33
De Beers Group Plc: Top Legal Advisors 33
De Beers Group Plc: Top Financial Advisors 33
De Beers Group Plc: Mergers and Acquisitions 34
De Beers Group Plc: Recent Developments 35
De Beers Group Plc: News and Events Summary 35
De Beers Group Plc: Business Expansion 38
De Beers Group Plc: Contracts 39
De Beers Group Plc: Corporate Governance 39
De Beers Group Plc: Financial Deals 39
De Beers Group Plc: Financial Performance 40
De Beers Group Plc: Red Flags/DistressSignals 40
De Beers Group Plc: Regulatory and Legal Events 41
De Beers Group Plc: Strategy and Operations 41
Appendix 43
Contact Us 43
Methodology 43
About MarketLine 44

List of Tables
Table 1: De Beers Group Plc: Key Facts
Table 2: De Beers Group Plc: Key Employees
Table 3: De Beers Group Plc: Company History
Table 4: De Beers Group Plc: Locations and Subsidiaries
Table 5: De Beers Group Plc: Key Competitors
Table 6: De Beers Group Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: De Beers Group Plc: M&A Activity by Geography (TTM*)
Table 8: De Beers Group Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: De Beers Group Plc: M&A Average Deal Size - Value (US$m)
Table 10: De Beers Group Plc: Targets and Partners
Table 11: De Beers Group Plc: Top Deals 2014 - 2018YTD*
Table 12: De Beers Group Plc: Legal Advisor Ranking by Value (US$m)
Table 13: De Beers Group Plc: Financial Advisor Ranking by Value (US$m)
Table 14: De Beers Group Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 15: De Beers Group Plc: M&A Activity by Geography (2014 - YTD*2018)
Table 16: De Beers Group Plc: News and Events Summary
Table 17: De Beers Group Plc: Business Expansion
Table 18: De Beers Group Plc: Contracts
Table 19: De Beers Group Plc: Corporate Governance
Table 20: De Beers Group Plc: Financial Deals
Table 21: De Beers Group Plc: Financial Performance
Table 22: De Beers Group Plc: Red Flags/DistressSignals
Table 23: De Beers Group Plc: Regulatory and Legal Events
Table 24: De Beers Group Plc: Strategy and Operations

List of Figures
Figure 1: De Beers Group Plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: De Beers Group Plc: M&A Activity by Geography (TTM*)
Figure 3: De Beers Group Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: De Beers Group Plc: M&A Average Deal Size - Value (US$m)
Figure 5: De Beers Group Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: De Beers Group Plc: M&A Activity by Geography (2014 - YTD*2018)

★海外企業調査レポート[De Beers Group Plc:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company offers monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed fo …
  • Westfalen Weser Netz GmbH:企業の戦略的SWOT分析
    Westfalen Weser Netz GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ad Scientiam:企業の製品パイプライン分析
    Summary Ad Scientiam is a medical technology company that offers digital biomarkers which collects physiological and behavioral data. It provides mobile application which monitors patients’ behaviors and sharers the data to healthcare professionals. Ad Scientiam serves individuals, healthcare profes …
  • GC Pharma (006280):企業の財務・戦略的SWOT分析
    GC Pharma (006280) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • PharmaEngine Inc (4162):製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaEngine Inc (PharmaEngine) is a biopharmaceutical company that discovers and develops cancer treatment drugs and related medicinal products. The company develops drugs for the treatment of cancer and Asian prevalent diseases. Its products include Onivyde a liposome encapsulation of irin …
  • Manitou Bf Sa:企業の戦略・SWOT・財務分析
    Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report Summary Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sberbank of Russia:企業の戦略・SWOT・財務情報
    Sberbank of Russia - Strategy, SWOT and Corporate Finance Report Summary Sberbank of Russia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Medigard Ltd (MGZ)-医療機器分野:企業M&A・提携分析
    Summary Medigard Ltd (Medigard), formerly Medisafe Instruments Pty Ltd is a medical device company that designs and develops retractable safety medical devices. The company offers products such as auto-retractable syringe, manual retractable syringe, blood collection device, intravenous valve and fl …
  • Advanced Materials Enterprises Co Ltd:企業の製品パイプライン分析2018
    Summary Advanced Materials Enterprises Co Ltd (AME) is a laboratory equipment supplier. The company manufactures group of high precision mechanical components. It offers laboratory and professional equipment, consumer and lifestyle products, industrial heating system, and healthcare products. AME’s …
  • Escalier Biosciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Escalier Biosciences BV (Escalier Biosciences) is a biopharmaceutical company, which develops small molecule medicines for the treatment of autoimmune disorders. Its pipeline products include topical and oral RAR-related orphan receptor gamma inverse agonists. Inhibition of RAR-related orpha …
  • Teijin Pharma Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Teijin Pharma Ltd (Teijin Pharma), a subsidiary of Teijin Ltd develops, manufactures and markets pharmaceutical and home healthcare products. The company offers a range of pharmaceutical products for the treatment of bone and joint diseases, respiratory diseases and cardiovascular and metabo …
  • Zara Investment (Holding) Co Ltd
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • STRATA Skin Sciences Inc (SSKN):企業の財務・戦略的SWOT分析
    STRATA Skin Sciences Inc (SSKN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Wood Group Mustang Inc-石油・ガス分野:企業M&A・提携分析
    Summary Wood Group Mustang, Inc. (Wood Group Mustang), a subsidiary of John Wood Group PLC is an engineering management company. It provides engineering, procurement, and construction management (EPC) services to clients across diverse end markets. The company’s service portfolio comprises design an …
  • Ryanair Holdings plc (RY4C):企業の財務・戦略的SWOT分析
    Ryanair Holdings plc (RY4C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Ishihara Sangyo Kaisha Ltd (4028):企業の財務・戦略的SWOT分析
    Ishihara Sangyo Kaisha Ltd (4028) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Del Taco Holdings, Inc.:企業の戦略・SWOT・財務情報
    Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Xspray Pharma AB (XSPRAY):製薬・医療:M&Aディール及び事業提携情報
    Summary Xspray Pharma AB (Xspray Pharma), formerly Xspray Microparticles AB, is a drug development company that develops and commercializes protein kinase inhibitors (PKI) for targeted cancer treatments. The company’s drug candidates include HyNap-Dasa, HyNap-Nilo and HyNap-Sora. Its protein kinase …
  • Allegra Orthopaedics Ltd (AMT)-医療機器分野:企業M&A・提携分析
    Summary Allegra Orthopaedics Ltd (Allegra), develops, manufactures and sells prosthetic implants and related orthopedic medical devices. Its major products include adult and adolescent clavicle fixation system and pin; shoulder implants; proximal humeral plates; trauma distal radial plates and syste …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆